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Observational studies have reported fairly consistent inverse associations between coffee
consumption and risk of type 2 diabetes, but this association has been little investigated
with regard to lesser degrees of hyperglycemia and other alterations in glucose homeosta-
sis. Additionally, the association between coffee consumption and diabetes has been rarely
investigated in South American populations. We examined the cross-sectional relationships
of coffee intake with newly diagnosed diabetes and measures of glucose homeostasis, in-
sulin sensitivity, and insulin secretion, in a large Brazilian cohort of middle-aged and elderly
individuals.
Methods
We used baseline data from 12,586 participants of the Longitudinal Study of Adult Health
(ELSA-Brasil). Logistic regression analyses were performed to examine associations be-
tween coffee consumption and newly diagnosed diabetes. Analysis of covariance was used
to assess coffee intake in relation to two-hour glucose from an oral glucose tolerance test,
fasting glucose, glycated hemoglobin, fasting and –2-hour postload insulin and measures of
insulin sensitivity.
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Results
We found an inverse association between coffee consumption and newly diagnosed diabe-
tes, after adjusting for multiple covariates [23% and 26% lower odds of diabetes for those
consuming coffee 2–3 and >3 times per day, respectively, compared to those reporting
never or almost never consuming coffee, (p = .02)]. An inverse association was also found
for 2-hour postload glucose [Never/almost never: 7.57 mmol/L,1 time/day: 7.48 mmol/L,
2-3 times/day: 7.22 mmol/L, >3 times/day: 7.12 mol/L, p<0.0001] but not with fasting glu-
cose concentrations (p = 0.07). Coffee was additionally associated with 2-hour postload in-
sulin [Never/almost never: 287.2 pmol/L,1 time/day: 280.1 pmol/L, 2–3 times/day: 275.3
pmol/L, >3 times/day: 262.2 pmol/L, p = 0.0005) but not with fasting insulin concentrations
(p = .58).
Conclusion
Our present study provides further evidence of a protective effect of coffee on risk of adult-
onset diabetes. This effect appears to act primarily, if not exclusively, through postprandial,
as opposed to fasting, glucose homeostasis.
Introduction
Over the past decade there has been an emergence of literature on the association between cof-
fee intake and type 2 diabetes, and a recent meta-analysis of studies on this topic concluded
that regular intake of caffeinated and decaffeinated coffee is inversely associated with risk of
type 2 diabetes in a dose-dependent manner [1].Yet, the preponderance of studies in this litera-
ture derives from high income countries where the confounding structures related to coffee
intake and diabetes may differ from those of low-middle income countries. Moreover, few epi-
demiological studies—and almost none in the less developed world—have reported on coffee
intake in relation to the various measures of glucose and insulin homeostasis. These are of par-
ticular interest as they provide insight into the key physiological aspects of glucose metabolism
affected by coffee intake. Those that have been conducted in high income countries suggest
that coffee consumption may affect postprandial blood glucose more strongly than fasting glu-
cose concentrations [2–6]. There is less consistent evidence for whether coffee is more strongly
associated with insulin resistance or pancreatic beta-cell function [2,4]. Lastly, no studies have
evaluated the effect of coffee intake on postprandial metabolism of glucose in individuals with
diabetes, after a meal test.
The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), a prospective cohort inves-
tigation of 15,105 Brazilian Adults from various regions of the country, provides a unique op-
portunity to study the association of coffee intake with diabetes and measures of glucose and
insulin homeostasis. To date, no known studies have investigated an association between coffee
and clinically measured diabetes in Brazil and elsewhere in South America. The extensive labo-
ratory measurements performed in ELSA-Brasil, including the use of a standardized post-meal
test and postprandial samples for those with known diabetes and an oral glucose tolerance test
(OGTT) with stored postload samples and measurements of glycated hemoglobin (HbA1c) for
all other participants, permits robust investigations into various physiological aspects of glucose
metabolism associated with coffee intake.
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We evaluated cross-sectional associations between coffee intake, newly diagnosed diabetes,
fasting plasma glucose, two-hour plasma glucose during a 75g oral-glucose tolerance test, gly-
cated hemoglobin, and measures of insulin resistance and beta-cell secretion. We also analyzed
the relationship between coffee intake and glucose/insulin metabolism in participants with pre-
viously diagnosed diabetes during a standardized meal test.
Methods
Study design and population
The Longitudinal Study of Adult Health (In Portuguese, Estudo Longitudinal de Saude do
Adulto or ELSA-Brasil) is a cohort study designed to identify risk factors for diabetes and car-
diovascular disease. The details of the study, including design, eligibility criteria, sources and
methods of recruitment, and measurements obtained, have been described in detail elsewhere
[7]. The cohort comprises 15,105 civil servants, aged 35 to 74 years at baseline (2008–2010),
who were sampled from universities or research institutions located in six cities of three differ-
ent regions of Brazil. All data for the current cross-sectional analyses were collected at baseline
during initial interviews (~1 hour) and the first clinic visit (~5 hours). The study was approved
by the Research and Ethics Committees of the institutions involved: Hospital de Clinicas de
Porto Alegre, Universidade Federal do Rio Grande do Sul, Universidade Federal do Espírito
Santo, Universidade Federal de Minas Gerais, Universidade Federal da Bahia, Universidade de
São Paulo, Fundação Osvaldo Cruz. All participants provided written, informed consent for
their clinical records to be used in this study prior to enrolment.
For the current investigation, we excluded participants with missing data at baseline for the
following variables: coffee intake (n = 28), body mass index (n = 6), waist-hip ratio (n = 8),
race/color (n = 184), education of mother (n = 366), leisure time physical activity (n = 221), al-
cohol intake (n = 26), various dietary variables (n = 72), hypertension (n = 13), and laboratory
measurements (n = 352). Some participants had missing data for two or more variables. We
further excluded those with previously diagnosed diabetes (n = 1473) from all main analyses,
except for those of coffee intake and glucose concentrations after a two-hour post-meal test.
Consequently, our main analyses were performed on 12,586 participants. Analyses of coffee
consumption with 2-hour post-meal glucose among those with previously diagnosed diabetes
were performed on 1,077 participants.
Exposure assessment
Coffee intake was assessed at the baseline examination through a validated 114-item Food Fre-
quency Questionnaire (FFQ) [8]. Reproducibility and relative validity of the FFQ compared to
three food records completed by a sub-set of participants and assessed through the intra-class
correlation coefficient (ICC) was shown to have a reproducibility ranging from 0.55 to 0.83
and a relative validity ranging from 0.20 to 0.72, depending on the nutrient value. Participants
were asked to provide information on their typical eating habits in the twelve months prior to
the baseline examination of the ELSA-Brasil. For assessment of habitual coffee intake, specifi-
cally, participants were asked to provide both the typical frequency with which they consumed
coffee (>3 times/day, 2–3 times/day, 1 time/day, 5–6 times/week, 2–4 times/week, 1 time/
week, 1–3 times/month, never/almost never) and the typical quantity of coffee consumed on
each occasion in relation to a reference cup size of 50 mL. Participants were further asked to
specify the type of coffee normally consumed (filter, instant, espresso, moka pot), whether this
coffee contained caffeine (caffeinated or decaffeinated), and whether additional items were typ-
ically added to the coffee (sugar, artificial sweetener, none).
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Outcome ascertainment
A 12-hour fasting blood sample was drawn by venipuncture soon after each participant arrived
at the baseline clinic visit. A two-hour 75g OGTT was then administered to participants without
known diabetes. A two-hour post-meal test, consisting of 47 g of rapidly digested carbohydrates
and 14 g of saturated fat from dairy products, was administered to those with known diabetes.
Glucose was measured centrally by the hexokinase method (ADVIA Chemistry; Siemens, Deer-
field, Illinois), percent glycated hemoglobin (A1C) was measured using a high-pressure liquid
chromatography (Bio-Rad Laboratories, Hercules, California), a National Glycohemoglobin
Standardization Program (NGSP) certified method, and insulin was measured with an immu-
noenzymatic assay (ELISA) (Siemens).
Diabetes status was classified using blood glucose measurements and self-reported informa-
tion. A participant was considered to have previously diagnosed diabetes when answering,
“yes” to either “Have you been previously told by a physician that you had diabetes (sugar in
the blood)?” or “Have you used medication for diabetes in the past 2 weeks?” The remaining
participants were evaluated for undiagnosed diabetes based on their laboratory values and
then classified as having diabetes if they reached the threshold for fasting plasma glucose
( 7.0 mmol/L), 2-hour postload plasma glucose ( 11.1 mmol/L), or HbA1c ( 6.5%) [9,10].
Given the age range of our participants, the vast majority of the previously undiagnosed cases
of diabetes will have type 2 diabetes [11].
Impaired glucose tolerance was defined as a two-hour postload glucose concentration
7.8 mmol/L and<11.1 mmol/L; impaired fasting glucose was defined as a fasting glucose
concentration6.1 mmol/L and<7.0 mmol/L [10,12]; and elevated HbA1c by a value 5.7%,
<6.5% [12]. Elevated fasting and two-hour postload insulin were defined as the top quartile of
their respective distribution of values, as follows: elevated fasting insulin 61.8 pmol/L, and el-
evated two-hour postload insulin447.0 pmol/L. In participants with previously known diabe-
tes, outcome of interest was elevated two-hour postprandial glucose (14.87 mmol/L, the top
quartile of its distribution).
Covariate assessment
A comprehensive set of questionnaires, tests, and measurements [13] was carried out. To con-
trol for confounding, we selected established risk factors for diabetes and factors known to be
associated with coffee consumption based on prior studies and theoretical considerations as
follows: age at baseline visit (years), race/skin color, educational achievement of the participant
and their mother, smoking status, alcohol use, physical activity (ascertained using the leisure
time section of the long version of the International Physical Activity Questionnaire [14]), fam-
ily history of diabetes, hypertension, and various dietary variables were ascertained by ques-
tionnaire, and blood pressure was measured using an oscillametric method (Omron HEM
705CP) [15]. Body mass index (BMI) was calculated as weight (kg) divided by height (m)
squared. The hepatic enzymes alanine aminotransferase and aspartate aminotransferase were
measured centrally by the Modified International Federation for Clinical Chemistry (enzymat-
ic) assay (ADVIA Chemistry) and gamma-glutamyltransferase was measured by the kinetic
calorimetric assay.
Statistical analyses
Baseline characteristics of the sample were summarized using unadjusted means and standard
deviations for continuous variables and frequencies and percentages for categorical variables ac-
cording to coffee intake category (Never/almost never [less than 1 time per month; referent cate-
gory], at least 1 time per month but no greater than 1 time per day, 2–3 times per day,>3 times
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per day). As quantity of coffee typically consumed on each occasion did not differ markedly by
frequency of coffee consumption, analyses were performed by frequency of coffee consumption
alone.
Analysis of covariance (ANCOVA) was performed to assess the association between catego-
ry of coffee intake and markers of glucose homeostasis as continuous variables. In participants
without previously known diabetes, outcomes of interest were fasting plasma glucose, 2-hour
postload plasma glucose, HbA1c, fasting insulin, two-hour postload insulin, homeostasis
model assessment of insulin resistance (HOMA-IR) and of β-cell function (HOMA-β), and the
insulin sensitivity index (ISI-composite) proposed by DeFronzo and Matsuda [16]. In partici-
pants with known diabetes who underwent the meal challenge test, outcome of interest was
two-hour postprandial glucose. Insulin, HOMA-IR, HOMA-β, and ISI-composite measures
were log-transformed then converted to geometric means. Multivariable logistic regression was
performed to generate odds ratios (ORs) and 95% confidence intervals for the association be-
tween category of coffee intake and diabetes and categorized markers of glucose homeostasis.
In participants without previously known diabetes, outcomes of interest were adult-onset dia-
betes, impaired fasting glucose, impaired glucose tolerance, HbA1c 5.7%,<6.5%, elevated
fasting insulin, and elevated two-hour postload insulin. For impaired glucose tolerance, im-
paired fasting glucose, and HbA1c 5.7%,<6.5% analyses, participants with newly diagnosed
diabetes were further excluded. Consequently, these analyses were performed on 11,245
participants.
Interaction terms were used to investigate whether associations differed between the follow-
ing pre-specified sub-groups: sex, age (median cut-point;<51 years,51 years), race/skin
color (white, non-white), BMI (<25 kg/m2,25 kg/m2), and smoking status (current, past,
never smoker). All statistical tests were two-sided and significance was defined at p<0.05. Sta-
tistical analyses were performed with SAS 9.4 (SAS Institute, Inc., Cary, North Carolina).
Results
Analyses were initially performed separately by method of coffee preparation (filtered, instant,
moka pot, espresso), type of coffee (caffeinated or decaffeinated), and addition of sweetener to
coffee (sugar, alternative sweetener, none) (S1 Table). As resulting sample sizes were frequently
small and there were no statistically significant differences across coffee preparation methods,
types of coffee, or addition of sweetener to coffee in relation to our main outcomes, all addi-
tional analyses were performed without consideration of these characteristics.
Baseline descriptive data of ELSA-Brasil participants by category of coffee intake are pre-
sented in Table 1. Most participants (around 58%) reported consuming coffee at least twice per
day, with 2928 (around 23% of the total) reporting consuming coffee more than 3 times per
day. Most participants reported typically consuming coffee that was filtered (83%), caffeinated
(98%), and with added sugar or artificial sweetener (59% and 28%, respectively). Participants
who reported greater daily coffee intake were more likely to consume alcohol and be current
smokers than those who reported less frequent coffee intake.
At baseline, we found 1341 (10.7%) cases of newly-diagnosed diabetes, 3083 (24.5%) cases
of impaired fasting glucose, 3114 (24.7%) cases of impaired glucose tolerance, and 2651
(21.1%) cases of HbA1c 5.7%,<6.5%.
We first present analyses of outcomes for the different categories of hyperglycemia and
insulinemia, followed by analyses of the laboratory variables and their HOMA derivatives
when considered in their continuous form. While infrequent or moderate (1 per day) con-
sumption of coffee was not consistently associated with glucose outcome measures, partici-
pants who consumed coffee 2–3 and>3 times per day had a 23% (6–37%) and 26% (8–40%)
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lower adjusted odds of newly diagnosed diabetes, respectively, compared to those who never
consumed coffee (P = 0.02) (Model 1, Table 2). Participants reporting consuming coffee>3
times per day also had a 29% (16–40%) lower adjusted odds of impaired glucose tolerance
(P<0.0001). Lastly, those consuming coffee both 2–3 and>3 times per day reported lower ad-
justed odds of elevated 2-hour postload insulin, compared to those who never consumed coffee
(P = 0.002). These associations did not change appreciably when we adjusted for hypertension
medication use or menopausal status (not shown) and remained significant after full covariate
adjustment (Model 3, Fig 1). Slight attenuation was seen in Model 4, which added potential
mediators. There were no appreciable associations between these higher coffee intake catego-
ries and impaired fasting glucose, HbA1c 5.7%,<6.5%, or elevated fasting insulin (Table 2).
When we analyzed associations between coffee intake and these outcomes in a continuous
fashion, thus describing the whole spectrum of glucose regulation, from normal to intermediate
states and diabetes, similar associations were observed (Table 3). Further, we found a signifi-
cant association of coffee intake with mean ISI-composite, which was maintained in our fully-
adjusted model. There was no evidence for interaction by sex, age, race/skin color, BMI, or
smoking status.
Finally, when we added the three enzyme measures of hepatic function, a further potential
mediator of the coffee-diabetes relationship, in an additional model, measures of association
with individual consumption frequencies hardly changed (OR [95% CI] 0.80 [.64-.99], 0.78
[.63-.97], 0.74 [.59-.94] for1/day, 2-3/day and>3/day, respectively, P for the overall associa-
tion = 0.08). The association with two-hour postload glucose also changed little: 7.56±.09, 7.43
±.08, 7.27±.08, and 7.20±.08 mmol/L for the categories never/almost never,1/day, 2-3/day,
and>3/day, respectively; P for the overall association<0.0001)
Table 1. Characterization of ELSA-Brasil participants (N = 12586) by frequency of coffee consumption per day, at baseline (2008–2010).
Variables Total Never/ almost never 1 2–3 >3
(N = 12586) (n = 1235) (n = 4044) (n = 4379) (n = 2928)
Male (%) 5663 (45.0%) 587 (47.5%) 1808 (44.7%) 1774 (40.5%) 1494 (51.0%)
Age, years (SD) 51.4 (8.9) 50.0 (9.1) 51.6 (9.3) 52.1 (9.1) 50.7 (7.8)
Race/color
Black 1912 (15.2%) 263 (21.3%) 675 (16.7%) 595 (13.6%) 379 (12.9%)
Brown (‘Pardo’) 3488 (27.7%) 346 (28.0%) 1098 (27.1%) 1237 (28.2%) 807 (27.6%)
White 6776 (53.8%) 587 (47.5%) 2122 (52.5%) 2412 (55.1%) 1655 (56.5%)
Othera 410 (3.3%) 39 (3.2%) 149 (3.7%) 135 (3.1%) 87 (3.0%)
Low educational attainmentb (%) 4794 (38.1%) 457 (37.0%) 1578 (39.0%) 1648 (37.6%) 1111 (37.9%)
BMI, kg/m2 (SD) 26.8 (4.6) 26.8 (5.0) 26.8 (4.6) 26.7(4.6) 26.8 (4.6)
WHR (SD) .89 (.09) .89 (.09) .89 (.09) .88 (.09) .89 (.09)
Current smoker (%) 1640 (13.0%) 76 (6.2%) 378 (9.4%) 436 (10.0%) 750 (25.6%)
Alcohol user (%) 8927 (70.9%) 713 (57.7%) 2863 (70.8%) 3143 (71.8%) 2208 (75.4%)
Low physical activityc (%) 10460 (83.1%) 1028 (83.2%) 3313 (81.9%) 3616 (82.6%) 2505 (85.6%)
Tea, g/day (SD) 46.7 (92.3) 46.5 (93.8) 44.4 (89.6) 46.9 (92.8) 49.6 (94.2)
Hypertension (%) 4064 (32.3%) 362 (29.3%) 1398 (34.6%) 1481 (33.8%) 823 (28.1%)
Family history of diabetes (%) 4584 (36.4%) 443 (35.9%) 1441 (35.6%) 1635 (37.3%) 1065 (36.4%)
Values are means and standard deviations for continuous variables and frequencies and percentages for categorical variables. Abbreviations: BMI, body
mass index (kg/m2); WHR, waist-hip ratio.
a
“Other”: those reporting their race/skin color as “Asian” or “Indigenous.
b Highest level of instruction completed was High school, or less.
c Typically engage in leisure time physical activity 1 day/week or less.
doi:10.1371/journal.pone.0126469.t001
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Table 2. Adjusted* associations of frequency of coffee consumption per day with newly diagnosed diabetes, intermediate hyperglycemia, and in-
sulin levels, from ELSA-Brasil (2008–2012) (N = 12586).
Never/almost never 1/day 2-3/day >3/day P-value†
(n = 1235) (n = 4044) (n = 4379) (n = 2928)
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Newly diagnosed diabetes
Model 1 1.00 .85 (.69–1.04) .77 (.63-.94) .74 (.60-.92) .02
Model 2 1.00 .82 (.66–1.01) .77 (.62-.94) .73 (.58-.91) .04
Model 3 1.00 .79 (.64-.98) .77 (.62-.96) .72 (.57-.90) .04
Model 4 1.00 .80 (.64-.99) .77 (.62-.95) .73 (.58-.92) .047
Impaired fasting glucose (IFG)a
Model 1 1.00 1.05 (.89–1.24) 1.06 (.90–1.26) 1.01 (.85–1.21) .81
Model 2 1.00 .99 (.84–1.18) 1.01 (.85–1.20) .96 (.80–1.15) .89
Model 3 1.00 .98 (.82–1.16) 1.01 (.85–1.21) .94 (.79–1.13) .71
Model 4 1.00 .99 (.83–1.18) 1.03 (.86–1.22) .96 (.80–1.15) .75
Impaired glucose tolerance (IGT)a
Model 1 1.00 .99 (.85–1.16) .86 (.74–1.01) .71 (.60-.84) <0.0001
Model 2 1.00 .97 (.83–1.14) .85 (.72–1.00) .73 (.61-.87) <0.0001
Model 3 1.00 .94 (.80–1.11) .85 (.72–1.00) .71 (.59-.84) <0.0001
Model 4 1.00 .97 (.81–1.16) .87 (.73–1.04) .74 (.61-.90) .001
HbA1c  5.7%, <6.5%a
Model 1 1.00 1.00 (.84–1.20) .99 (.83–1.18) 1.06 (.89–1.27) .73
Model 2 1.00 1.03 (.86–1.23) 1.05 (.88–1.25) 1.06 (.88–1.28) .93
Model 3 1.00 1.03 (.86–1.23) 1.05 (.88–1.26) 1.06 (.88–1.28) .92
Model 4 1.00 1.03 (.86–1.23) 1.06 (.89–1.26) 1.07 (.89–1.29) .88
Elevated fasting insulinb
Model 1 1.00 .96 (.83–1.12) .92 (.79–1.06) .87 (.75–1.02) .23
Model 2 1.00 .94 (.81–1.09) .91 (.78–1.05) .91 (.78–1.07) .59
Model 3 1.00 .91 (.77–1.07) .93 (.79–1.09) .88 (.74–1.05) .54
Model 4 1.00 .91 (.77–1.07) .93 (.79–1.09) .88 (.74–1.05) .55
Elevated 2-hour postload insulinc
Model 1 1.00 .86 (.75–1.00) .85 (.74-.98) .75 (.64-.87) .002
Model 2 1.00 .87 (.75–1.00) .86 (.74-.99) .80 (.68-.93) .0496
Model 3 1.00 .82 (.70-.96) .86 (.73–1.00) .76 (.64-.90) .01
Model 4 1.00 .82 (.70-.96) .86 (.74–1.00) .76 (.64-.89) .01
a For IFG, IGT, HbA1c analyses, n = 11245 after exclusion of participants with newly diagnosed diabetes.
b  61.8 pmol/l (top quartile of distribution).
c  447.0 pmol/l (top quartile of distribution).
† P-value for the test of any association between coffee consumption and the outcome of interest
* Model 1: adjusted for sex, age (years), ELSA-Brasil center.
Model 2: + race/color (white, pardo, black, asian/indigenous), education (high school or less, some university or more), education of mother (high school
or less, some university or more), smoking status (current, former, never smoker), alcohol intake (user, former user, never user), leisure time physical
activity level (engage in physical activity one time per week or less, engage in physical activity two or more times per week), hypertension, family history of
diabetes, daily fruit consumption, daily vegetable consumption, dairy product intake (g/day), beef intake (g/day), white rice intake (g/day), soda intake (g/
day), juice intake (g/day), tea intake (g/day), % kcal from fat
Model 3: + body mass index, waist-hip ratio, C-reactive protein.
Model 4: + Magnesium. Further adjustment for insulin measures (fasting and 2-hour postload) for diabetes, fasting glucose, two-hour postload glucose,
and HbA1c analyses.
doi:10.1371/journal.pone.0126469.t002
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In analyses on participants with known diabetes, no associations were found between fre-
quency of coffee consumption and elevated two-hour post-prandial glucose (OR [95% CI]:1/
day: .81 [.46–1.41]; 2-3/day: .90 [.52–1.56];>3/day: 1.06 [.60–1.86] vs. Never/almost never
[referent]; p-value = .57) or two-hour postprandial glucose (Mean [SE] mmol/l: Never/almost
never: 11.9 [0.6];1/day: 12.0 [0.3]; 2-3/day: 12.0 [0.3];>3/day: 12.3 [0.3]; p-value: .85). Anal-
yses performed with coffee consumption categorized by quantity consumed instead of by fre-
quency produced similar results (S2 Table).
Discussion
In this cross-sectional analysis of 12,586 Brazilian adults 35–74 years of age who had not been
previously diagnosed with diabetes, we found an association between higher intake of coffee
(two or more times per day) and lower odds of newly diagnosed diabetes—most likely type 2—
assessed at the baseline clinical examination. This association appeared to be primarily driven
by impaired glucose and insulin regulation after a glucose challenge. We did not observe asso-
ciations between coffee and glycated hemoglobin levels. We also did not find associations be-
tween coffee and measures of glucose regulation during a two hour post-meal test in
participants with previously diagnosed diabetes.
Fig 1. Fully-adjusted (Model 3) associations of frequency of coffee consumption per day with newly diagnosed diabetes and intermediate
hyperglycemia, from ELSA-Brasil (2008–2012) (N = 12586). For IFG, IGT, HbA1c analyses, n = 11245 after exclusion of participants with newly
diagnosed diabetes.
doi:10.1371/journal.pone.0126469.g001
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Table 3. Adjusted*Mean (SE) values for metabolic measures according to the relationship with frequency of coffee consumption per day.
ELSA-Brasil, 2008–2012 (N = 12586).
Never/almost never 1 2–3 >3 P-value†
(n = 1235) (n = 4044) (n = 4379) (n = 2928)
Fasting glucose (mmol/L)
Model 1 5.95±0.03 5.96±0.02 5.91±0.01 5.92±0.02 .07
Model 2 5.99±0.04 5.98±0.03 5.94±0.03 5.95±0.03 .10
Model 3 5.98±0.04 5.97±0.03 5.94±0.03 5.94±0.03 .22
Model 4 5.99±0.04 5.97±0.03 5.93±0.03 5.93±0.03 .08
Two-hour postload glucose (mmol/L)
Model 1 7.57±0.07 7.48±0.04 7.22±0.04 7.12±0.05 <0.0001
Model 2 7.60±0.10 7.47±0.08 7.24±0.08 7.18±0.09 <0.0001
Model 3 7.57±0.10 7.41±0.08 7.22±0.08 7.13±0.08 <0.0001
Model 4 7.57±0.09 7.44±0.08 7.26±0.08 7.20±0.08 <0.0001
HbA1c (%)
Model 1 5.3±0.02 5.3±0.01 5.3±0.01 5.3±0.01 .62
Model 2 5.4±0.03 5.4±0.02 5.4±0.02 5.4±0.02 .75
Model 3 5.4±0.03 5.4±0.02 5.4±0.02 5.4±0.02 .62
Model 4 5.4±0.03 5.4±0.02 5.4±0.02 5.4±0.02 .61
Fasting insulin (pmol/L)
Model 1 32.8±0.8 33.1±0.5 33.4±0.5 32.4±0.6 .58
Model 2 31.9±1.1 32.0±0.9 32.4±1.0 32.3±1.0 .87
Model 3 31.8±1.0 31.3±0.8 32.5±0.8 31.6±0.8 .10
Model 4 31.8±1.0 31.3±0.8 32.5±0.8 31.6±0.8 .10
Two-hour postload insulin (pmol/L)
Model 1 287.2±6.4 280.1±3.5 275.3±3.3 262.2±3.9 .0005
Model 2 272.3±8.5 265.9±6.9 261.9±6.8 256.2±6.8 .08
Model 3 269.4±7.8 259.6±6.2 260.9±6.3 250.9±6.3 .02
Model 4 269.4±7.8 259.6±6.3 260.9±6.3 250.9±6.3 .02
HOMA-IR
Model 1 1.43±0.04 1.45±0.02 1.45±0.02 1.41±0.03 .58
Model 2 1.40±0.05 1.40±0.04 1.42±0.04 1.41±0.05 .97
Model 3 1.39 ±0.04 1.37±0.04 1.42±0.04 1.38±0.04 .16
Model 4 1.39±0.04 1.37±0.04 1.42±0.04 1.38±0.04 .16
HOMA-β
Model 1 48.1 ±0.5 47.5±.3 48.4±.3 48.2±.3 .14
Model 2 46.8 ±0.7 46.7±.6 47.4±.6 47.3±.6 .17
Model 3 47.0 ±0.7 47.0±.6 47.5±.6 47.5±.6 .33
Model 4 47.0 ±0.7 47.0±.6 47.5±.6 47.5±.6 .32
ISI (composite)
Model 1 5.28 ±0.13 5.34±.07 5.47±.07 5.73±.09 .003
Model 2 5.47 ±0.18 5.57±.15 5.67±.16 5.77±.17 .17
Model 3 5.53 ±0.16 5.74±.14 5.68±.14 5.92±.15 .02
Model 4 5.54 ±0.16 5.72±.13 5.63±.13 5.88±.14 .02
Values presented are Mean ± SE (Standard error). Fasting insulin, two-hour postload insulin, HOMA-IR, HOMA-β, & ISI (composite) are presented as
Geometric means. To convert to conventional units: mmol*18.018 = mg/dl; pmol/l*.167 = μIU/ml.
† P-value for the test of any association between coffee consumption and the outcome of interest
* Model 1: adjusted for sex, age (years), ELSA-Brasil center.
Model 2: + race/color (white, pardo, black, asian/indigenous), education (high school or less, some university or more), education of mother (high school
or less, some university or more), smoking status (current, former, never smoker), alcohol intake (user, former user, never user), leisure time physical
activity level (engage in physical activity one time per week or less, engage in physical activity two or more times per week), hypertension, family history of
diabetes, daily fruit consumption, daily vegetable consumption, dairy product intake (g/day), beef intake (g/day), white rice intake (g/day), soda intake (g/
day), juice intake (g/day), tea intake (g/day), % kcal from fat.
Model 3: + body mass index, waist-hip ratio, C-reactive protein.
Model 4: + Magnesium. Further adjustment for insulin measures (fasting and 2-hour postload) for fasting glucose, two-hour postload glucose, and
HbA1c analyses.
doi:10.1371/journal.pone.0126469.t003
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This is the first comprehensive assessment of the association between coffee intake and glu-
cose regulation conducted in a Brazilian population. Our findings extend beyond those of Ma-
chado et al. [17] which addressed the association only in those with self-reported diabetes.
Our finding of overall stronger inverse associations between coffee and impaired glucose
tolerance, as compared with impaired fasting glucose, is consistent with previous studies [3,6],
and provides further confirmation that the apparent protective effect of coffee consumption
acts primarily through postprandial glucose homeostasis. We also noted a significant inverse
association between coffee and postload insulin concentrations, but no associations with other
markers of insulin resistance in the fasting state: HOMA-IR and fasting insulin concentrations.
We did not observe associations of coffee with HOMA-β concentrations, a measure of insulin
secretion, but did find an association with ISI composite, which aggregates fasting and postload
insulin and glucose values.
There has been considerable inconsistency in analyses examining the effect of coffee on
measures of both insulin resistance and secretion. In a cross-sectional analysis of 1,440 Japa-
nese adults, higher coffee consumption was associated with decreased insulin resistance, but
not with insulin secretion, as evaluated through the homeostatic model assessment [18]. Like-
wise, in a study of 1,088 elderly Swedish men, habitual coffee consumption was associated with
increased insulin sensitivity as measured using a hyperinsulinemic-euglycemic clamp, but not
with early insulin response during an OGTT [19]. However, in a separate Swedish study, higher
coffee consumption was associated with a reduced risk of insulin resistance in women, and
with low β-cell function in women with impaired glucose tolerance [4]. In a cross-sectional
study of 954 multi-ethnic non-diabetic adults from the Insulin Resistance Atherosclerosis
Study, Masters et al. (2012) reported stronger associations between caffeinated coffee and insu-
lin sensitivity, while decaffeinated coffee was favorably related to measures of beta cell function,
as assessed through frequently sampled intravenous glucose tolerance tests [2]. As noted in
their analysis, few studies to date appear to have examined whether participants reporting reg-
ular coffee consumption tend to consume caffeinated as opposed to decaffeinated coffee and
what potential differential effects these beverages may have on insulin activity. Separate analy-
ses of the effects of caffeinated and decaffeinated coffee on all insulin measures in our study
overlapped. However, as only two percent of our participants reported consuming decaffeinat-
ed coffee, we may have lacked the statistical power to detect a differential association. Mecha-
nistic research is warranted to elucidate the extent to which coffee may enhance insulin
secretion.
The lack of an association found between coffee intake and two hour postprandial glucose
among participants with previously diagnosed diabetes is difficult to interpret as antidiabetic
medication usage may well have masked any relationship of coffee with postprandial glucose
levels. Additionally, knowledge of diabetes status may have modified dietary intake, including
coffee consumption.
Major components of coffee include caffeine, chlorogenic acid, magnesium, adiponectin,
quinides, and various other micronutrients. Several mechanisms have been proposed to explain
the apparent protective effect of coffee consumption on type 2 diabetes. Although caffeine was
originally considered to be the primary contributor to coffee’s effect on glucose metabolism,
various studies reporting protective effects of decaffeinated coffee on diabetes now appear to
suggest that other components of coffee may be more responsible for its antidiabetic effect.
Magnesium has been proposed as a possible contributor to glucose metabolism by modulating
insulin receptor activity through effects on hormone-receptor affinity or membrane viscosity
[20]. We found that adjusting for magnesium intake in all of our analyses did not attenuate as-
sociations. This is consistent with more recent reports on this topic [21, 22]. Because coffee is a
rich source of anti-oxidants, and sub-clinical inflammation has been implicated in the
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development of insulin resistance, it was proposed that coffee may improve insulin sensitivity
by decreasing inflammation. An eight week randomized controlled trial found favourable ef-
fects of coffee intake on adiponectin concentrations which, aside from anti-inflammatory ac-
tions, act through AMPK (5' adenosine monophosphate-activated protein kinase) to modulate
glucose uptake which may contribute to beneficial metabolic effects of longer term coffee in-
take [23]. Similarly, a recent trial showed a positive correlation between changes in caffeine
level, a biomarker of coffee ingestion, and changes in adiponectin level when comparing zero
versus 8 cups/day of coffee intake [24]. However, a cross-sectional study exploring the extent
to which adiponectin and the inflammatory marker C-reactive protein (CRP) explained the as-
sociation between regular coffee consumption and diabetes did not find evidence that this ef-
fect is mediated by anti-inflammatory mechanisms [5]. Likewise, adjusting for C-reactive
protein in our analyses did not substantially weaken the observed associations. Chlorogenic
acid, the second most abundant component of coffee, is also believed to play a role in reducing
postprandial plasma glucose [25]. It may reduce hepatic glucose output through inhibition of
glucose-6-phosphatase activity, may attenuate glucose absorption rates by inhibiting the sodi-
um-dependent glucose transporters, and may reduce oxidative stress through its antioxidant
properties [26]. Furthermore, it has been demonstrated that chlorogenic acid stimulates glu-
cose transport in skeletal muscle through activation of AMPK [27]. Additionally, the roasting
of coffee transforms some chlorogenic acid into quinides, compounds that have been shown to
enhance insulin sensitivity in rats [28]. Whether chlorogenic acid mediates the observed associ-
ations requires further study. It has further been suggested that coffee may contribute to im-
provements in glucose homeostasis through the stimulation of incretins, gastrointestinal
hormones responsible for regulation of postprandial insulin and glucagon production by the
pancreas [29]. For example, two experimental studies in humans reported that caffeinated and
decaffeinated coffee acutely decreased concentrations of glucose-dependent insulinotropic pep-
tide (GIP) [30, 31], with one of the studies additionally reporting that decaffeinated coffee
acutely increased concentrations of glucagon-like peptide 1 (GLP-1) [30]. However, a more re-
cent study failed to find an effect of decaffeinated coffee on either GIP or GLP-1 responses dur-
ing an oral glucose tolerance test [32]. A stimulatory effect of coffee on activity of incretins
would be consistent with our finding of a stronger association of coffee with postprandial, as
opposed to fasting, glucose concentrations. Lastly, the role of sex hormone binding globulin
(SHBG) as a potential mediator between caffeinated coffee intake and reduced risk of diabetes
among postmenopausal women has been proposed [33].
Some of the strengths of our study include the use of a standardized post-meal test and post-
prandial samples for those with known diabetes and a standard 75 g-OGTT with stored post-
load samples and measurements of glycated hemoglobin for all other participants. Previously
unknown diabetes was determined on the basis of blood glucose measurements. Through col-
lecting data on methods of coffee preparation, types of coffee typically consumed, and addition
of sweetener, we were able to investigate potential differential effects on outcomes of interest.
Another strength of this present analysis is its relatively large size—to our knowledge, the larg-
est study to date to assess the effect of coffee in analyses that included a variety of glucose and
insulin measures. Furthermore, as the first investigation of its kind in South America, findings
from our study extend the apparent protective effect of coffee in relation to diabetes, observed
solely in high income country and Asian contexts up until this point. Lastly, we believe this is
the first study to examine the association between coffee and plasma glucose following a two-
hour post-meal test among those with known diabetes.
Some limitations of this present study deserve mention. This study was cross-sectional, lim-
iting interpretation with regards to causal direction of associations, although the exclusion of
those with known diabetes at baseline from our primary analyses would limit the possibility of
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reverse causation as an explanation for our findings. The use of a food frequency questionnaire
to assess dietary intake can often be associated with measurement error, although this is likely
to be non-differential with regard to diabetes status, which would underestimate protective ef-
fects reported, if present. Owing to the large size of the ELSA-Brasil study, we were not able to
assess insulin resistance and secretion using more sophisticated methods, and thus relied on
the relatively more crude plasma insulin levels and HOMAmeasurements. However, valida-
tion studies have shown these measures to be relatively well correlated with more accurate
measures of insulin resistance and secretion such as the hyperinsulinemic-euglycemic clamp
[34]. Lastly, although attempts were made to statistically adjust for possible confounding vari-
ables, we cannot rule out the possibility or residual or unknown confounding in our analyses.
Our data add to the now overwhelming evidence that coffee intake may have metabolic ef-
fects with potential benefits to those at risk for diabetes and the metabolic syndrome [1]. Fur-
ther exploration of both the addition of sugar or artificial sweeteners and the quantities
typically added is needed to gain insight as to the potential antagonistic effects of these addi-
tives on diabetes risk. Additionally, as milk and other dairy products (e.g., creamer) are often
added to coffee in different parts of the world, investigation into their possible effects on the
coffee-diabetes relationship is warranted, given the suggestion that dairy products may protect
against the development of diabetes [35].
Conclusion
Middle-aged and elderly Brazilian participants who reported consuming coffee two or more
times per day had lower odds of presenting newly diagnosed diabetes. This association ap-
peared to be driven by mechanisms operating postprandially rather than in the fasting state.
We did not find appreciable differences between those who reported consuming regular vs. de-
caffeinated coffee, or those who reported consuming their coffee with sugar, artificial sweetener
vs. no additives. Thus, our findings support the hypothesis that habitual coffee consumption is
part of a dietary pattern that is protective against type 2 diabetes.
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